Live Breaking News & Updates on பாஷ் ஆரோக்கியம் அமெரிக்காக்கள்
Stay updated with breaking news from பாஷ் ஆரோக்கியம் அமெரிக்காக்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aleor Dermaceuticals gets tentative USFDA nod for Efinaconazole topical solution thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Alembic Pharmaceuticals (Alembic) today announced that its joint venture Aleor Dermaceuticals (Aleor) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Efinaconazole Topical Solution, 10%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. (Bausch). Efinaconazole Topical Solution, 10% is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) ....
Aleor Dermaceuticals receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10% Posted On: 2021-04-07 22:47:15 (Time Zone: Arizona, USA) Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Efinaconazole Topical Solution, 10%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. (Bausch). Efinaconazole Topical Solution, 10% is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes. Efinaconazole Topical Solution, 10% has an estimated market size of US$ 233 million for twelve months ending December 2020 according to IQVIA. Aleor has settled the case with Bausch Health and. will ....
Alembic Pharmaceuticals gained 1.1% to Rs 983.95 after the drug maker announced that its joint venture has received US drug regulator s tentative approval for efinaconazole topical solution.Alembic Pharma on Thursday announced that its joint venture Aleor Dermaceuticals (Aleor) has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for efinaconazole topical solution. Efinaconazole topical solution is used to treat fungal toenail infections (infections that may cause nail discoloration, splitting, or pain). Efinaconazole topical solution is in a class of medications called antifungals. The product has an estimated market size of $233 million for twelve months ending December 2020 according to IQVIA. ....
Read more about Sensex, Nifty scale record high on Business Standard. Key benchmark indices are trading firm in early trade on buying demand in index pivotals. At 9:25 IST, the barometer index, the S&P BSE Sensex, was up 366.54 points or 0.78% at 47,340.08. The Nifty 50 index was up 106.30 points or 0.77% at ....